CSIMarket
 


Invitae Corporation  (NVTA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Invitae's Working Capital Ratio for Trailing Twelve Months Period

NVTA's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

NVTA Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 39.8 % 9.13 % 13.27 % -24.98 % -27.44 %
Y / Y Current Assets Growth -48.14 % -49.54 % -51.07 % -41.2 % -46.57 %
Working Capital Ratio for Trailing Twelve Months Period 3.33 4.22 5.12 6.33 6.79
Total Ranking # 1071 # 897 # 812 # 753 # 712
Seq. Current Liabilities Growth 4.24 % -20.09 % 75.94 % -4.61 % -18.62 %
Seq. Current Assets Growth -16.14 % -10.52 % -27.25 % -5.01 % -18.4 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $158 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 3.33 below Invitae Corporation average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Laboratories industry 26 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Invitae. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about NVTA
Working Capital Ratio NVTA in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 27
Sector # 678
S&P 500 # 1518


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.17 5.47 2.86
(Dec 31 2016)   (Jun 30 2018)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Laboratories Industry Working Capital Ratio for Trailing Twelve Months Period
Fulgent Genetics Inc   8.79 
Castle Biosciences Inc   8.26 
Bioaffinity Technologies Inc   7.62 
Dermtech Inc   7.61 
Exagen Inc   7.20 
Absci Corp  6.88 
Butterfly Network inc   6.85 
Omniab Inc   6.44 
Guardant Health Inc   6.37 
Science 37 Holdings Inc   6.23 
Personalis Inc   5.71 
Sera Prognostics Inc   5.64 
Caredx Inc   5.05 
Veracyte inc   4.91 
Ispecimen inc   4.78 
Invitae Corporation  4.24 
Hologic Inc  4.03 
Natera inc   3.99 
Incyte Corporation  3.77 
Burning Rock Biotech Limited  3.38 
Nano x Imaging Ltd  3.29 
Bionexus Gene Lab Corp   3.22 
Biocept Inc   2.99 
American Shared Hospital Services  2.90 
Luna Innovations Inc  2.78 
Fortrea Holdings Inc   2.60 
Exact Sciences Corporation  2.58 
Vyant Bio Inc   2.28 
Enzo Biochem Inc  2.23 
Inotiv Inc   2.02 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com